4,344 Shares in CVS Health Corporation (NYSE:CVS) Acquired by Silver Oak Securities Incorporated

Silver Oak Securities Incorporated purchased a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 4,344 shares of the pharmacy operator's stock, valued at approximately $292,000.

A number of other institutional investors and hedge funds have also made changes to their positions in CVS. Hopwood Financial Services Inc. acquired a new stake in CVS Health in the 4th quarter valued at about $29,000. McIlrath & Eck LLC boosted its stake in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares during the last quarter. MV Capital Management Inc. boosted its stake in shares of CVS Health by 63.9% during the 1st quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock worth $50,000 after purchasing an additional 289 shares during the last quarter. Dunhill Financial LLC boosted its stake in shares of CVS Health by 147.2% during the 1st quarter. Dunhill Financial LLC now owns 749 shares of the pharmacy operator's stock worth $51,000 after purchasing an additional 446 shares during the last quarter. Finally, Atwood & Palmer Inc. boosted its stake in shares of CVS Health by 228.0% during the 1st quarter. Atwood & Palmer Inc. now owns 820 shares of the pharmacy operator's stock worth $56,000 after purchasing an additional 570 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Down 1.1%

Shares of CVS traded down $0.75 during mid-day trading on Monday, reaching $66.68. 6,418,905 shares of the stock traded hands, compared to its average volume of 10,833,454. The firm has a market cap of $84.35 billion, a price-to-earnings ratio of 15.91, a P/E/G ratio of 0.97 and a beta of 0.57. The stock has a fifty day simple moving average of $65.11 and a 200 day simple moving average of $61.71. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $72.51. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The firm's revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.31 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.99%. CVS Health's dividend payout ratio (DPR) is 63.48%.

Insider Buying and Selling

In other news, Director Guy P. Sansone purchased 1,570 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the purchase, the director owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.22% of the company's stock.

Analyst Ratings Changes

CVS has been the topic of several analyst reports. Robert W. Baird raised their price target on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Barclays set a $79.00 price objective on shares of CVS Health and gave the stock an "overweight" rating in a report on Monday, June 2nd. Wells Fargo & Company reiterated an "overweight" rating and set a $84.00 price objective (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Finally, Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and a consensus target price of $75.06.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.